Skip to main content
SpringerLink
Log in

Chemotherapy with highest risk of peripheral neuropathy

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kishimoto S, et al. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials. European Journal of Cancer 115: 111-119, 24 May 2019. Available from: URL: http://doi.org/10.1016/j.ejca.2019.04.023

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chemotherapy with highest risk of peripheral neuropathy. Reactions Weekly 1758, 5 (2019). https://doi.org/10.1007/s40278-019-63551-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-63551-5

Search

Navigation